These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 634850)

  • 21. [Malignant lymphoma. New aspects].
    Abrahamsen AF; Normann T; Host H
    Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1967-72. PubMed ID: 4588400
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combined chemotherapy for malignant lymphomas (author's transl)].
    Zhou JC; Sun Y; Ye ZS; Xin MZ
    Zhonghua Zhong Liu Za Zhi; 1980 Dec; 2(4):300-3. PubMed ID: 7297405
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

  • 24. [Advantages and hazards of combined chemotherapy in malignant lymphomas (author's transl)].
    Klener P; Donner L
    Sb Lek; 1978 Jun; 80(6):185-9. PubMed ID: 675144
    [No Abstract]   [Full Text] [Related]  

  • 25. [Non-Hodgkin's malignant lymphoma with central nervous involvement--report of 7 cases].
    Nagata T; Kobayashi A; Aiba K; Yokoyama K; Ikeda K; Kobayashi T; Chiene T; Kuraishi Y; Meguro S; Ichiba K; Abe M
    Gan No Rinsho; 1983 Jun; 29(7):838-42. PubMed ID: 6876452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-Hodgkin's lymphoma in children: present treatment strategy (author's transl)].
    Maurus R; Otten J
    Rev Med Brux; 1981 Mar; 2(3):259-63. PubMed ID: 7232937
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the significance of multiagent combination chemotherapy for primary gastric malignant lymphoma (author's transl)].
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H; Hirota T; Itabashi M
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1310-6. PubMed ID: 7334264
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of malignant lymphoma].
    Horikoshi N; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 30. [Direct results of using a new multimodal chemotherapy plan in malignant non-Hodgkin lymphomas].
    Tolmacheva EL; Arkhipova NE; Tentsova IA; Chernova MK; Burova GF
    Sov Med; 1981; (6):82-3. PubMed ID: 7280804
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of immunoproliferative diseases--achievements and perspectives].
    Cepelja Z
    Lijec Vjesn; 1983; 105(2-3):129-31. PubMed ID: 6855428
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of polychemotherapy of patients with non-Hodgkin's lymphoma].
    Varga G; Krizsa F; Vezendi K; Kálmán A; Cserháti I
    Orv Hetil; 1980 Jul; 121(28):1697-700. PubMed ID: 7005810
    [No Abstract]   [Full Text] [Related]  

  • 34. Microwave adjuvant to radiotherapy and chemotherapy for advanced lymphoma.
    Nelson AJ; Holt JA
    Med J Aust; 1980 Apr; 1(7):311-3. PubMed ID: 6771502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of centrocytic-centroblastic lymphomas. Comparison of treatment results with whole body irradiation and polychemotherapy].
    Bamberg M; Schulz U; Ohl S; Holfeld H; Lenz W
    Strahlentherapie Sonderb; 1978; 75():104-9. PubMed ID: 400194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
    Jandl H; Franke A; Kammerer R; Spormann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
    Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H
    Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
    Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
    Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
    [No Abstract]   [Full Text] [Related]  

  • 40. Deferral of initial therapy for advanced indolent lymphomas.
    Portlock CS
    Cancer Treat Rep; 1982 Mar; 66(3):417-9. PubMed ID: 7037178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.